Autologous Cell Therapy Market Size & Share Forecast Report - 2032

Autologous Cell Therapy Market - By Therapy (Autologous Cellular Immunotherapies, Autologous Stem Cell Therapy), By Source (Bone Marrow, Epidermis), By Application (Cancer, Orthopedics), By End-use (Hospitals & Clinics, Research Centers) & Forecast 2023 - 2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology

1.1&nbsp;&nbsp;&nbsp; Market definition

1.2&nbsp;&nbsp;&nbsp; Base estimates &amp; calculations

1.3&nbsp;&nbsp;&nbsp; Forecast parameters

1.4&nbsp;&nbsp;&nbsp; COVID-19 impact analysis at global level

1.5&nbsp;&nbsp;&nbsp; Data validation

1.6&nbsp;&nbsp;&nbsp; Data Sources

1.6.1&nbsp;&nbsp;&nbsp; Primary

1.6.2&nbsp;&nbsp;&nbsp; Secondary

1.6.2.1&nbsp;&nbsp;&nbsp;Paid sources

1.6.2.2&nbsp;&nbsp;&nbsp;Public sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Autologous cell therapy industry 3600 synopsis, 2018 &ndash; 2032

2.1.1&nbsp;&nbsp;&nbsp; Business trends

2.1.2&nbsp;&nbsp;&nbsp; Regional trends

2.1.3&nbsp;&nbsp;&nbsp; Therapy trends

2.1.4&nbsp;&nbsp;&nbsp; Source trends

2.1.5&nbsp;&nbsp;&nbsp; Application trends

2.1.6&nbsp;&nbsp;&nbsp; End-use trends

Chapter 3&nbsp;&nbsp;&nbsp;Autologous Cell Therapy Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp;Advancements in cell manufacturing technologies

3.2.1.2&nbsp;&nbsp;&nbsp;Rising prevalence of chronic disease

3.2.1.3&nbsp;&nbsp;&nbsp;Growing demand for personalized therapies

3.2.1.4&nbsp;&nbsp;&nbsp;Increasing R&amp;D activities undertaken by companies for autologous cell therapy

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp;Systemic immunological reactions

3.2.2.2&nbsp;&nbsp;&nbsp;High cost of autologous cell therapy

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.3.1&nbsp;&nbsp;&nbsp; By therapy

3.3.2&nbsp;&nbsp;&nbsp; By source

3.3.3&nbsp;&nbsp;&nbsp; By application

3.3.4&nbsp;&nbsp;&nbsp; By end-use

3.4&nbsp;&nbsp;&nbsp; COVID- 19 impact analysis

3.5&nbsp;&nbsp;&nbsp; Regulatory landscape

3.6.1&nbsp;&nbsp;&nbsp; U.S.

3.6.2&nbsp;&nbsp;&nbsp; Europe

3.6&nbsp;&nbsp;&nbsp; Technological landscape

3.7&nbsp;&nbsp;&nbsp; Future potential

3.8&nbsp;&nbsp;&nbsp; Porter&#39;s analysis

3.9&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2022

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis, 2022

4.3&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.4&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.5&nbsp;&nbsp;&nbsp; Strategy dashboard

4.6&nbsp;&nbsp;&nbsp; Strategy outlook matrix

Chapter 5&nbsp;&nbsp;&nbsp;Autologous Cell Therapy Market Size and Forecast, By Therapy (USD Million)

5.1&nbsp;&nbsp;&nbsp; Key trends, by therapy

5.2&nbsp;&nbsp;&nbsp; Autologous Cellular Immunotherapies

5.3&nbsp;&nbsp;&nbsp; Autologous Stem Cell Therapy

Chapter 6&nbsp;&nbsp;&nbsp;Autologous Cell Therapy Market Size and Forecast, By Source (USD Million)

6.1&nbsp;&nbsp;&nbsp; Key trends, by source

6.2&nbsp;&nbsp;&nbsp; Bone Marrow

6.3&nbsp;&nbsp;&nbsp; Epidermis

6.4&nbsp;&nbsp;&nbsp; Mesenchymal Stem Cells

6.5&nbsp;&nbsp;&nbsp; Other sources

Chapter 7&nbsp;&nbsp;&nbsp;Autologous Cell Therapy Market Size and Forecast, By Application (USD Million)

7.1&nbsp;&nbsp;&nbsp; Key trends, by application

7.2&nbsp;&nbsp;&nbsp; Cancer

7.3&nbsp;&nbsp;&nbsp; Cardiovascular Disorders

7.4&nbsp;&nbsp;&nbsp; Neurodegenerative Disorders

7.5&nbsp;&nbsp;&nbsp; Orthopedics

7.6&nbsp;&nbsp;&nbsp; Other applications

Chapter 8&nbsp;&nbsp;&nbsp;Autologous Cell Therapy Market Size and Forecast, By End-use (USD Million)

8.1&nbsp;&nbsp;&nbsp; Key trends, by end-use

8.2&nbsp;&nbsp;&nbsp; Hospitals &amp; Clinics

8.3&nbsp;&nbsp;&nbsp; Ambulatory Surgical Centers

8.4&nbsp;&nbsp;&nbsp; Research Centers

8.5&nbsp;&nbsp;&nbsp; Other end-users

Chapter 9&nbsp;&nbsp;&nbsp;Autologous Cell Therapy Market Size and Forecast, By Region (USD Million)

9.1&nbsp;&nbsp;&nbsp; Key trends, by region

9.2&nbsp;&nbsp;&nbsp; North America

9.2.1&nbsp;&nbsp;&nbsp; U.S.

9.2.2&nbsp;&nbsp;&nbsp; Canada

9.3&nbsp;&nbsp;&nbsp; Europe

9.3.1&nbsp;&nbsp;&nbsp; Germany

9.3.2&nbsp;&nbsp;&nbsp; UK

9.3.3&nbsp;&nbsp;&nbsp; France

9.3.4&nbsp;&nbsp;&nbsp; Spain

9.3.5&nbsp;&nbsp;&nbsp; Italy

9.3.6&nbsp;&nbsp;&nbsp; Rest of Europe

9.4&nbsp;&nbsp;&nbsp; Asia Pacific

9.4.1&nbsp;&nbsp;&nbsp; Japan

9.4.2&nbsp;&nbsp;&nbsp; China

9.4.3&nbsp;&nbsp;&nbsp; India

9.4.4&nbsp;&nbsp;&nbsp; Australia

9.4.5&nbsp;&nbsp;&nbsp; Rest of Asia Pacific

9.5&nbsp;&nbsp;&nbsp; Latin America

9.5.1&nbsp;&nbsp;&nbsp; Brazil

9.5.2&nbsp;&nbsp;&nbsp; Mexico

9.5.3&nbsp;&nbsp;&nbsp; Argentina

9.5.4&nbsp;&nbsp;&nbsp; Rest of Latin America

9.6&nbsp;&nbsp;&nbsp; MEA

9.6.1&nbsp;&nbsp;&nbsp; South Africa

9.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

9.6.3&nbsp;&nbsp;&nbsp; Rest of MEA

Chapter 10&nbsp;&nbsp;&nbsp;Company Profiles

10.1&nbsp;&nbsp;&nbsp; BrainStorm Cell Therapeutics, Inc.

10.2&nbsp;&nbsp;&nbsp; Holostem Terapie Avanzate S.r.l.

10.3&nbsp;&nbsp;&nbsp; Lisata Therapeutics

10.4&nbsp;&nbsp;&nbsp; Lonza Group AG

10.5&nbsp;&nbsp;&nbsp; Opexa Therapeutics, Inc.

10.6&nbsp;&nbsp;&nbsp; Novartis AG

10.7&nbsp;&nbsp;&nbsp; Tegoscience

10.8&nbsp;&nbsp;&nbsp; Autolus Therapeutics

10.9&nbsp;&nbsp;&nbsp; Bristol-Myers Squibb Company

10.10&nbsp;&nbsp;&nbsp; Corning Incorporated

10.11&nbsp;&nbsp;&nbsp; Bio Elpida.

10.12&nbsp;&nbsp;&nbsp; Vericel Corporation

10.13&nbsp;&nbsp;&nbsp; Catalent, Inc.

10.14&nbsp;&nbsp;&nbsp; Sartorius AG 
&nbsp;

Autologous Cell Therapy Market

Get a free sample of this report